CIK: 0001773206 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value ($000): $333,932 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | LHC GROUP INC | 125,000 | $21,790 | 6.5% | $160.67 | — | COM | 50187A107 |
| DGX | QUEST DIAGNOSTICS INC | 120,000 | $13,675 | 4.1% | $92.35 | +3.1% | COM | 74834L100 |
| BMY | BRISTOL-MYERS SQUIBB CO | 200,000 | $11,760 | 3.5% | $45.53 | +5.3% | COM | 110122108 |
| — | ARENA PHARMACEUTICALS INC | 175,000 | $11,016 | 3.3% | $51.15 | — | COM NEW | 040047607 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 80,000 | $9,867 | 3.0% | $75.53 | +31.6% | COM | 09061G101 |
| CRL | CHARLES RIV LABS INTL INC | 55,000 | $9,589 | 2.9% | $159.60 | 0.0% | COM | 159864107 |
| — | GW PHARMACEUTICALS PLC | 75,000 | $9,204 | 2.8% | $92.10 | — | ADS | 36197T103 |
| COR | AMERISOURCEBERGEN CORP | 90,000 | $9,069 | 2.7% | $79.57 | 0.0% | COM | 03073E105 |
| — | NEVRO CORP | 75,000 | $8,960 | 2.7% | $109.07 | — | COM | 64157F103 |
| — | CHEMOCENTRYX INC | 150,000 | $8,631 | 2.6% | $40.02 | — | COM | 16383L106 |
| — | BLUEPRINT MEDICINES CORP | 110,000 | $8,580 | 2.6% | $71.28 | — | COM | 09627Y109 |
| — | SAGE THERAPEUTICS INC | 195,000 | $8,108 | 2.4% | $57.12 | — | COM | 78667J108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 150,000 | $8,022 | 2.4% | $37.79 | +22.5% | COM | 00847X104 |
| CYTK | CYTOKINETICS INC | 340,000 | $8,014 | 2.4% | $13.11 | +43.0% | COM NEW | 23282W605 |
| DHR | DANAHER CORPORATION | 45,000 | $7,957 | 2.4% | $131.31 | +6.6% | COM | 235851102 |
| HUM | HUMANA INC | 20,000 | $7,755 | 2.3% | $341.90 | +4.0% | COM | 444859102 |
| — | SEATTLE GENETICS INC | 45,000 | $7,646 | 2.3% | $169.91 | — | COM | 812578102 |
| REGN | REGENERON PHARMACEUTICALS | 12,000 | $7,484 | 2.2% | $564.49 | 0.0% | COM | 75886F107 |
| — | CATALENT INC | 100,000 | $7,330 | 2.2% | $51.95 | — | COM | 148806102 |
| MOH | MOLINA HEALTHCARE INC | 40,000 | $7,119 | 2.1% | $170.30 | 0.0% | COM | 60855R100 |
| — | NUVASIVE INC | 125,000 | $6,958 | 2.1% | $55.66 | — | COM | 670704105 |
| AZN | ASTRAZENECA PLC | 125,000 | $6,611 | 2.0% | $44.66 | — | SPONSORED ADR | 046353108 |
| DXCM | DEXCOM INC | 15,000 | $6,081 | 1.8% | $89.45 | 0.0% | COM | 252131107 |
| UHS | UNIVERSAL HLTH SVCS INC | 65,000 | $6,038 | 1.8% | $97.41 | 0.0% | CL B | 913903100 |
| AMGN | AMGEN INC | 25,000 | $5,897 | 1.8% | $191.68 | 0.0% | COM | 031162100 |
| MRK | MERCK & CO. INC | 75,000 | $5,800 | 1.7% | $65.09 | -3.4% | COM | 58933Y105 |
| LLY | LILLY ELI & CO | 35,000 | $5,746 | 1.7% | $143.90 | 0.0% | COM | 532457108 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $5,709 | 1.7% | $99.93 | — | COM | 60468T105 |
| — | MOMENTA PHARMACEUTICALS INC | 150,000 | $4,991 | 1.5% | $33.27 | — | COM | 60877T100 |
| EXAS | EXACT SCIENCES CORP | 55,000 | $4,782 | 1.4% | $81.19 | -1.6% | COM | 30063P105 |
| ABT | ABBOTT LABS | 50,000 | $4,572 | 1.4% | $75.99 | +7.8% | COM | 002824100 |
| — | HORIZON THERAPEUTICS PUB LTD | 80,000 | $4,446 | 1.3% | $55.58 | — | SHS | G46188101 |
| BAX | BAXTER INTL INC | 50,000 | $4,305 | 1.3% | $77.66 | 0.0% | COM | 071813109 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 35,000 | $4,178 | 1.3% | $110.02 | 0.0% | COM | 98956P102 |
| MCK | MCKESSON CORP | 25,000 | $3,836 | 1.1% | $140.83 | -1.1% | COM | 58155Q103 |
| NVST | ENVISTA HOLDINGS CORPORATION | 175,000 | $3,691 | 1.1% | $18.75 | 0.0% | COM | 29415F104 |
| HALO | HALOZYME THERAPEUTICS INC | 135,000 | $3,619 | 1.1% | $21.23 | +6.2% | COM | 40637H109 |
| EXEL | EXELIXIS INC | 150,000 | $3,561 | 1.1% | $18.29 | +26.7% | COM | 30161Q104 |
| GOSS | GOSSAMER BIO INC | 270,000 | $3,510 | 1.1% | $12.58 | 0.0% | COM | 38341P102 |
| PODD | INSULET CORP | 18,000 | $3,497 | 1.0% | $191.17 | 0.0% | COM | 45784P101 |
| AKBA | AKEBIA THERAPEUTICS INC | 250,000 | $3,395 | 1.0% | $8.29 | +24.8% | COM | 00972D105 |
| — | MODERNA INC | 50,000 | $3,211 | 1.0% | — | — | Put | 60770K957 |
| DNLI | DENALI THERAPEUTICS INC | 130,000 | $3,143 | 0.9% | $21.68 | +8.5% | COM | 24823R105 |
| RVTY | PERKINELMER INC | 30,000 | $2,943 | 0.9% | $87.56 | +3.1% | COM | 714046109 |
| — | CHANGE HEALTHCARE INC | 250,000 | $2,800 | 0.8% | $11.20 | — | COM | 15912K100 |
| — | DICERNA PHARMACEUTICALS INC | 110,000 | $2,794 | 0.8% | $22.03 | — | COM | 253031108 |
| — | INTRA CELLULAR THERAPIES INC | 100,000 | $2,567 | 0.8% | — | — | Call | 46116X901 |
| ABBV | ABBVIE INC | 25,000 | $2,455 | 0.7% | $70.50 | 0.0% | COM | 00287Y109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 20,000 | $2,440 | 0.7% | $110.51 | 0.0% | COM | 64125C109 |
| — | ZOGENIX INC | 90,000 | $2,431 | 0.7% | $27.01 | — | COM NEW | 98978L204 |
| — | AMARIN CORP PLC | 350,000 | $2,422 | 0.7% | $6.92 | — | SPONS ADR NEW | 023111206 |
| FATE | FATE THERAPEUTICS INC | 70,000 | $2,402 | 0.7% | $25.29 | +17.9% | COM | 31189P102 |
| MGNX | MACROGENICS INC | 70,000 | $1,954 | 0.6% | $17.37 | 0.0% | COM | 556099109 |
| ONC | BEIGENE LTD | 10,000 | $1,884 | 0.6% | $188.40 | — | SPONSORED ADR | 07725L102 |
| — | WALGREENS BOOTS ALLIANCE INC | 40,000 | $1,696 | 0.5% | $45.75 | — | COM | 931427108 |
| PTCT | PTC THERAPEUTICS INC | 30,000 | $1,522 | 0.5% | $49.14 | 0.0% | COM | 69366J200 |
| — | GENMARK DIAGNOSTICS INC | 100,000 | $1,471 | 0.4% | $14.71 | — | COM | 372309104 |
| — | KARYOPHARM THERAPEUTICS INC | 75,000 | $1,421 | 0.4% | $19.17 | — | COM | 48576U106 |
| INCY | INCYTE CORP | 10,000 | $1,040 | 0.3% | $96.40 | 0.0% | COM | 45337C102 |
| — | BRISTOL-MYERS SQUIBB CO | 150,000 | $537 | 0.2% | $3.01 | — | RIGHT 99/99/9999 | 110122157 |